Blood Cancer Journal (Feb 2021)
Serum paraprotein persistence and size determine outcome in a cohort of patients with a modern definition of plasmacytoma with up to 19 years of follow up
- Elisabet E. Manasanch,
- Chutima Kunacheewa,
- Catherine M. Claussen,
- Hans C. Lee,
- Sheeba K. Thomas,
- Jill Gunther,
- Chelsea C. Pinnix,
- Bouthaina S. Dabaja,
- Behrang Amini,
- Raymond Alexanian,
- Robert Z. Orlowski,
- Wenli Dong,
- Lei Feng,
- Donna M. Weber
Affiliations
- Elisabet E. Manasanch
- Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center
- Chutima Kunacheewa
- Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center
- Catherine M. Claussen
- Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center
- Hans C. Lee
- Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center
- Sheeba K. Thomas
- Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center
- Jill Gunther
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center
- Chelsea C. Pinnix
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center
- Bouthaina S. Dabaja
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center
- Behrang Amini
- Department of Radiodiagnostic Imaging, The University of Texas MD Anderson Cancer Center
- Raymond Alexanian
- Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center
- Robert Z. Orlowski
- Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center
- Wenli Dong
- Department of Biostatistics, The University of Texas MD Anderson Cancer Center
- Lei Feng
- Department of Biostatistics, The University of Texas MD Anderson Cancer Center
- Donna M. Weber
- Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center
- DOI
- https://doi.org/10.1038/s41408-021-00419-1
- Journal volume & issue
-
Vol. 11,
no. 2
pp. 1 – 5
Abstract
No abstracts available.
